Paola Pedrazzi

Summary

Affiliation: Federico II University
Country: Italy

Publications

  1. doi request reprint Acquired inhibitors of coagulation factors: part I-acquired hemophilia A
    Antonio Coppola
    Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 38:433-46. 2012
  2. doi request reprint Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges
    Antonio Coppola
    Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 38:79-94. 2012
  3. doi request reprint Bleeding and thrombosis in multiple myeloma and related plasma cell disorders
    Antonio Coppola
    Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 37:929-45. 2011
  4. doi request reprint Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Br J Haematol 150:515-28. 2010
  5. doi request reprint Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Via S Pansini, 5 80131 Naples, Italy
    Haemophilia 16:13-9. 2010
  6. doi request reprint Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism
    Antonio Coppola
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Semin Thromb Hemost 35:683-94. 2009
  7. doi request reprint Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    J Thromb Haemost 7:1809-15. 2009
  8. ncbi request reprint Prophylaxis in people with haemophilia
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Thromb Haemost 101:674-81. 2009
  9. pmc Primary prophylaxis in children with haemophilia
    Antonio Coppola
    Centro di Riferimento Regionale per le Emocoagulopatie, Universita Federico II, Napoli, Italia
    Blood Transfus 6:s4-11. 2008
  10. doi request reprint Desmopressin in inherited disorders of platelet function
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University of Naples, Naples, Italy
    Haemophilia 14:31-9. 2008

Collaborators

Detail Information

Publications14

  1. doi request reprint Acquired inhibitors of coagulation factors: part I-acquired hemophilia A
    Antonio Coppola
    Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 38:433-46. 2012
    ..Present knowledge about this often overlooked and challenging condition has significantly increased following establishment of recent national and international studies, as will also be reviewed in this article...
  2. doi request reprint Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges
    Antonio Coppola
    Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 38:79-94. 2012
    ..Scientific evidence, current clinical strategies, and open issues of prophylaxis in children with hemophilia will be addressed in this review...
  3. doi request reprint Bleeding and thrombosis in multiple myeloma and related plasma cell disorders
    Antonio Coppola
    Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Semin Thromb Hemost 37:929-45. 2011
    ..The clinical impact of bleeding and thrombotic complications in patients with PCD, with emphasis on MM, will be discussed in this review, reporting the current knowledge about pathophysiologic mechanisms and implications for management...
  4. doi request reprint Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Br J Haematol 150:515-28. 2010
    ..This article reviews the available literature evidence and clinical implications with current recommendations on ITI management, and highlights the issues still unsolved...
  5. doi request reprint Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Via S Pansini, 5 80131 Naples, Italy
    Haemophilia 16:13-9. 2010
    ....
  6. doi request reprint Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism
    Antonio Coppola
    Department of Clinical and Experimental Medicine, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples, Italy
    Semin Thromb Hemost 35:683-94. 2009
    ..These considerations should be taken into account when assessing the need and modalities of primary and secondary thromboprophylaxis in patients carrying inherited thrombophilic traits...
  7. doi request reprint Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    J Thromb Haemost 7:1809-15. 2009
    ..Predictors of ITI outcome are still debated, and the role of F8 gene mutations in this is not well established...
  8. ncbi request reprint Prophylaxis in people with haemophilia
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Federico II University Hospital, Naples, Italy
    Thromb Haemost 101:674-81. 2009
    ....
  9. pmc Primary prophylaxis in children with haemophilia
    Antonio Coppola
    Centro di Riferimento Regionale per le Emocoagulopatie, Universita Federico II, Napoli, Italia
    Blood Transfus 6:s4-11. 2008
    ..Open issues concerning optimal regimens and barriers to the implementation of prophylaxis are also discussed...
  10. doi request reprint Desmopressin in inherited disorders of platelet function
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University of Naples, Naples, Italy
    Haemophilia 14:31-9. 2008
    ..This review will focus the available clinical data and the open issues of DDAVP in this setting...
  11. ncbi request reprint Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University of Naples, Naples, Italy
    Blood Coagul Fibrinolysis 18:199-201. 2007
    ....
  12. ncbi request reprint Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding
    A Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Haemophilia 12:90-4. 2006
    ..Long-term prophylaxis with Haemate P has been shown to be safe, effective (also in terms of quality of life) and cost saving in this patient with severe gastrointestinal bleeding due to MVA and VWD...
  13. ncbi request reprint Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype
    Antonio Coppola
    Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
    Br J Haematol 131:100-8. 2005
    ..In parallel with long-lasting tHcy-lowering effects, a short-course 5-MTHF supplementation reduces in vivo formation of 8-iso-PGF2alpha in this population, supporting the antioxidant protective effects of folate in vascular disease...
  14. ncbi request reprint Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management
    A Coppola
    Centro di Coordinamento Regionale per le Emocoagulopatie, Cattedra di Gastroenterologia, Dipartimento di Medicina Clinica e Sperimentale, Universita Federico II, Napoli, Italy
    J Intern Med 252:271-5. 2002
    ....